Search details
1.
Clinical application of liquid biopsy in cancer patients.
BMC Cancer
; 22(1): 413, 2022 Apr 15.
Article
in English
| MEDLINE | ID: mdl-35428225
2.
An Open-Label, Single-Arm, Two-Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.
Oncologist
; 25(5): e782-e788, 2020 05.
Article
in English
| MEDLINE | ID: mdl-31852810
3.
Patients with head and neck cancer may need more intensive pain management to maintain daily functioning: a multi-center study.
Support Care Cancer
; 27(5): 1663-1672, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30112724
4.
A nationwide survey of adherence to analgesic drugs among cancer patients in Taiwan: prevalence, determinants, and impact on quality of life.
Support Care Cancer
; 27(8): 2857-2867, 2019 Aug.
Article
in English
| MEDLINE | ID: mdl-30552596
5.
Pharmacokinetic study of bortezomib administered intravenously in Taiwanese patients with multiple myeloma.
Hematol Oncol
; 36(1): 238-244, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-28626947
6.
Exogenous C8-Ceramide Induces Apoptosis by Overproduction of ROS and the Switch of Superoxide Dismutases SOD1 to SOD2 in Human Lung Cancer Cells.
Int J Mol Sci
; 19(10)2018 Oct 02.
Article
in English
| MEDLINE | ID: mdl-30279365
7.
The epidemiologic transition of thalassemia and associated hemoglobinopathies in southern Taiwan.
Ann Hematol
; 96(2): 183-188, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27891555
8.
Rapid Screening for Deleted Form of ß-thalassemia by Real-Time Quantitative PCR.
J Clin Lab Anal
; 31(1)2017 Jan.
Article
in English
| MEDLINE | ID: mdl-27526959
9.
Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
BMC Cancer
; 16: 583, 2016 08 02.
Article
in English
| MEDLINE | ID: mdl-27485439
10.
Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.
Oral Dis
; 21(7): 872-8, 2015 Oct.
Article
in English
| MEDLINE | ID: mdl-26173098
11.
MDM2 promoter polymorphism and p53 codon 72 polymorphism in chronic myeloid leukemia: the association between MDM2 promoter genotype and disease susceptibility, age of onset, and blast-free survival in chronic phase patients receiving imatinib.
Mol Carcinog
; 53(12): 951-9, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-23818300
12.
MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
BMC Cancer
; 14: 809, 2014 Nov 04.
Article
in English
| MEDLINE | ID: mdl-25369863
13.
Comprehensive Analysis and Drug Modulation of Human Endogenous Retrovirus in Hepatocellular Carcinomas.
Cancers (Basel)
; 15(14)2023 Jul 18.
Article
in English
| MEDLINE | ID: mdl-37509325
14.
IgG4-related disease with bone marrow involvement mimicking multiple myeloma.
Br J Haematol
; 177(5): 673, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28439907
15.
P-selectin-dependent platelet aggregation and apoptosis may explain the decrease in platelet count during Helicobacter pylori infection.
Blood
; 115(21): 4247-53, 2010 May 27.
Article
in English
| MEDLINE | ID: mdl-20097880
16.
Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan.
BMC Cancer
; 12: 503, 2012 Oct 31.
Article
in English
| MEDLINE | ID: mdl-23114019
17.
Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
Ann Hematol
; 91(4): 587-95, 2012 Apr.
Article
in English
| MEDLINE | ID: mdl-21997849
18.
Single-cell RNA sequencing of immune cells in patients with acute gout.
Sci Rep
; 12(1): 22130, 2022 12 22.
Article
in English
| MEDLINE | ID: mdl-36550178
19.
Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study.
Hemasphere
; 6(12): e803, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36452029
20.
NOVEL-1st: an observational study to assess the safety and efficacy of nilotinib in newly diagnosed patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase in Taiwan.
Int J Hematol
; 115(5): 704-712, 2022 May.
Article
in English
| MEDLINE | ID: mdl-35212915